145 related articles for article (PubMed ID: 10643859)
1. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
[No Abstract] [Full Text] [Related]
2. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
Borgna-Pignatti C; Bezzi TM; Reverberi R
Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
[No Abstract] [Full Text] [Related]
3. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
Corso M; Ravindranath TM
Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
[TBL] [Abstract][Full Text] [Related]
4. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-associated gallbladder lithiasis in children.
Stabile A; Ferrara P; Marietti G; Maresca G
Eur J Pediatr; 1995 Jul; 154(7):590. PubMed ID: 7556332
[No Abstract] [Full Text] [Related]
6. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone associated hemolysis.
Maraspin V; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 1999 May; 111(9):368-70. PubMed ID: 10407998
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
Citak A; Garratty G; Ucsel R; Karabocuoglu M; Uzel N
J Paediatr Child Health; 2002 Apr; 38(2):209-10. PubMed ID: 12031011
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
Imam SN; Wright K; Bhoopalam N; Choudhury A
J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone-induced immune hemolytic anemia.
Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
[TBL] [Abstract][Full Text] [Related]
11. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone induced hemolysis complicated by acute renal failure.
Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis.
Liu W; Yu D
Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095
[No Abstract] [Full Text] [Related]
14. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
Boggs SR; Cunnion KM; Raafat RH
Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
[TBL] [Abstract][Full Text] [Related]
16. An unusual complication of sternal and clavicle osteomyelitis in a child with sickle cell disease.
Al-Fifi SH; Al-Qahtani SM; Al-Binali AM; Annobil SH
Saudi Med J; 2002 May; 23(5):589-90. PubMed ID: 12070588
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
Northrop MS; Agarwal HS
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
Quillen K; Lane C; Hu E; Pelton S; Bateman S
Pediatr Infect Dis J; 2008 Apr; 27(4):357-8. PubMed ID: 18316983
[TBL] [Abstract][Full Text] [Related]
20. Transfusion med illustrated: Ceftriaxone-induced acute hemolytic anemia.
Tobian AA; Shirey RS; Savage WJ
Transfusion; 2010 Aug; 50(8):1647-8. PubMed ID: 20931689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
